Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2014

Jun 10, 2014

30237_dirs_2014-06-10_66f42ff9-4b20-45d3-b649-19c6f7a2917d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2014-06-09

Reporting Person: Boyle James T. Jr. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-09 Common Stock M 9800 $84.86 Acquired 35621 Direct
2014-06-09 Common Stock M 28800 $84.86 Acquired 64421 Direct
2014-06-09 Common Stock S 38600 $103.00 Disposed 25821 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-09 Non-qualified Stock Options $84.86 M 9800 Disposed 2022-05-23 Common Stock (9800) Direct
2014-06-09 Non-qualified Stock Options $84.86 M 28800 Disposed 2022-05-23 Common Stock (28800) Direct

Footnotes

F1: The price of $103.00 per share represents a weighted average of sales prices ranging from $102.81 to $103.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.

F3: The option vests in three equal annual installments beginning on the date reflected in this column.